Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Portage Biotech Inc. (ATON : NSDQ)

• Company Description    AlphaTON Capital is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. AlphaTON Capital Corp., formerly known as Portage Biotech Inc., is based in DOVER, Del. Number of Employees: 4

• Price / Volume Information    Yesterday's Closing Price: $5.45 Daily Weekly Monthly 20 Day Moving Average: 86,667 shares Shares Outstanding: 1.05 (millions) Market Capitalization: $5.72 (millions) Beta: 0.25 52 Week High: $13.20 52 Week Low: $2.95 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -38.02% -39.14% 12 Week -1.55% -10.62% Year To Date 5.49% -5.81%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL CLARENCE THOMAS BUILDING P.O. BOX 4649 ROAD TOWN - TORTOLA,D8 VG1110 - ph: 302-219-5556 fax: - ahudders@golenbock.com http://www.portagebiotech.com

• General Corporate Information    Officers Alexander Pickett - Chief Executive Officer and Director Andrea E. Park - Chief Financial Officer Adam Melero - Controller Gregory Bailey - Director Steven Mintz - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: FIN-MISC SVCS Sector: Finance CUSIP: G7185A136 SIC: 2834 Fiscal Year Fiscal Year End: March Last Reported Quarter: 09/01/24 Next Expected EPS Date: 09/16/25 Share - Related Items Shares Outstanding: 1.05 Most Recent Split Date: 8.00 (0.05:1) Beta: 0.25 Market Capitalization: $5.72 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/16/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 78.28% vs. Previous Quarter: 20.25% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - 2.02 12/31/24 - - Quick Ratio 06/30/25 - - 03/31/25 - 2.02 12/31/24 - - Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - -0.79 12/31/24 - - Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©